Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
16,359,854
-
Total 13F shares
-
12,244,439
-
Share change
-
+9,096,204
-
Total reported value
-
$313,500,808
-
Price per share
-
$25.60
-
Number of holders
-
56
-
Value change
-
+$233,088,276
-
Number of buys
-
45
-
Number of sells
-
9
Institutional Holders of ASSEMBLY BIOSCIENCES, INC. - Common Stock (ASMB) as of Q3 2025
As of 30 Sep 2025,
ASSEMBLY BIOSCIENCES, INC. - Common Stock (ASMB) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,244,439 shares.
The largest 10 holders included
GILEAD SCIENCES, INC., FARALLON CAPITAL MANAGEMENT LLC, RA CAPITAL MANAGEMENT, L.P., Commodore Capital LP, JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, Frazier Life Sciences Management, L.P., Blackstone Inc., Point72 Asset Management, L.P., and Parkman Healthcare Partners LLC.
This page lists
56
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.